Buprenorphine Dose and Time to Discontinuation Among Patients With Opioid Use Disorder in the Era of Fentanyl is a research paper published in JAMA Network Open (2023). On theSindex it has a DataRank of 0. It has been cited 112 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIMH NIH HHS
Grant: R25 MH083620
NIDA NIH HHS
Grant: K23 DA055695
NIDA NIH HHS
Grant: UG3 DA056880
National Institutes of Health
Grant: 1UG3DA056880-01
Identifying optimal buprenorphine dosing for OUD treatment and prevention of overdose
National Institutes of Health
Grant: 5K23DA055695-02
Injectable Extended-Release Buprenorphine (XR-B) in a Correctional Setting: A Pilot Randomized Controlled Trial
National Institutes of Health
Grant: 5R25MH083620-12
Brown University Community and Clinical Research Training Program
Fields of Study
MeSH Terms
Keywords
Additional file 1 of Treatment setting and buprenorphine discontinuation: an analysis of multi-state insurance claims
Additional file 1 of Treatment setting and buprenorphine discontinuation: an analysis of multi-state insurance claims